Previously (last year?), Don said that Zenith has 2 potentially registration-enabling trials ongoing (See slide 5 here)

1. TNBC; presumably NCT03901469 (phase 2, recruiting, 179 patients)

2. mCRPC; presumably NCT04986423 (phase 2, recruiting, 200 patients)

The RVX AGM - at 31:00 - Don says Zenith is no longer pursuing TNBC because someone else got there first.

I think this was pretty bad news. He kind of off-the-cuff "oh, yeah, this happened".

Thought I'd highlight it.